31.20
Real-Time Quote
 +0.10 / +0.32%
Today’s Change
27.51
Today|||52-Week Range
32.96
+1.86%
Year-to-Date
Intra-Cellular Commences Phase III Schizophrenia Study - Analyst Blog
Nov 26 / Zacks.com
Stock Market News for November 19, 2014 - Market News
Nov 19 / Zacks.com
CNBC'S Catherine Boyle Doesn't Think A Pfizer/AstraZeneca Deal Will Happen Soon
Nov 26 / Benzinga
Merck KGaA Ties Up with Pfizer on Immuno-oncology Deal - Analyst Blog
Nov 18 / Zacks.com
3 Stocks Reiterated As A Buy: PFE, MU, YHOO
Nov 26 / TheStreet.com
Will Pfizer's Dividend Be Safe?
Nov 18 / MotleyFool.com
5 Things Pfizer, Inc.'s Management Wants You to Know
Nov 26 / MotleyFool.com
AstraZeneca fleshes out standalone strategy
Nov 18 / FT.com
S&P 500 bull run defies doubts over valuations
Nov 26 / FT.com
Puma Biotechnology Falls on Disappointing Neratinib Data - Analyst Blog
Nov 17 / Zacks.com
AstraZeneca comes into focus as Pfizer's cooling-off period ends
Nov 25 / FT.com
3 Stocks the Smartest Investors Are Buying Right Now
Nov 17 / MotleyFool.com
3 Companies That Could Slash Their Dividends
Nov 24 / MotleyFool.com
Stocks: Six things to know before the open
Nov 17 / CNNMoney.com
Why These Big Pharma Stocks Could Plunge Next Year
Nov 24 / MotleyFool.com
AbbVie Inc. vs. Pfizer Inc.: Which Is the Better Dividend Stock?
Nov 16 / MotleyFool.com
Frontrunning: November 6
Nov 23 / Investing Channel
Pfizer Inc. (PFE): New Analyst Report from Zacks Equity Research - Zacks Equity Resea...
Nov 14 / Zacks.com
Get Your Wallet Out: Global Drug Spending is About to Hit a Dubious Milestone
Nov 23 / MotleyFool.com
The Top 15 Broker Darlings of the Dow: Current Top Analyst Picks
Nov 12 / TheOnlineInvestor.com
11 Things You Need to Know About GMO Labeling
Nov 22 / MotleyFool.com
Ackman-led team takes 10% stake in Zoetis
Nov 11 / FT.com
Rules of the Game: Portfolio Review Time
Nov 21 / TheStreet.com
UCB caps week of pharma dealmaking
Nov 07 / FT.com
Rules of the Game: Reviewing Portfolio Allocations
Nov 21 / TheStreet.com
AstraZeneca promotes standalone prospects
Nov 06 / FT.com
3 Stocks Reiterated As A Buy: PFE, WFC, PEP
Nov 21 / TheStreet.com
Bill Ackman wins Allergan insider trading lawsuit
Nov 04 / FT.com
The Crucial Thing You're Missing About Many Dividend Stocks
Nov 20 / MotleyFool.com
AstraZeneca strikes deals on cancer drugs
Nov 04 / FT.com
Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews
Nov 19 / Zacks.com
Aggressive tax avoidance troubles large investors
Nov 02 / FT.com
Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
Nov 19 / Zacks.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.